PWM
IMRX icon

Palumbo Wealth Management’s Immuneering IMRX Stock Holding History

Palumbo Wealth Management’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95.2K Buy
19,083
+413
+2% +$2.09K 0.02% 236
2026
Q1 		$98.4K Sell
18,670
-44,603
-70% -$229K 0.02% 220
2025
Q4 		$416K Buy
63,273
+14,221
+29% +$91.3K 0.1% 140
2025
Q3 		$343K Buy
+49,052
New +$255K 0.11% 120

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Palumbo Wealth Management's IMRX Position: Q2 2026 in Review

Palumbo Wealth Management increased its Immuneering (IMRX) stake by 2.2% in Q2 2026, buying an estimated $2.09K and bringing the position to 19,083 shares worth $95.2K. The position accounts for 0.02% of the portfolio, ranked #236.

Palumbo Wealth Management first reported a position in IMRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $416K in Q4 2025. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Palumbo Wealth Management held 19,083 shares of Immuneering worth $95.2K as of Q2 2026.
  • Palumbo Wealth Management bought 413 Immuneering shares in Q2 2026, an estimated $2.09K.
  • Immuneering made up 0.02% of Palumbo Wealth Management's portfolio in Q2 2026, its #236 holding.
  • Palumbo Wealth Management first reported a position in Immuneering in Q3 2025 and has held it in 4 quarters since.
  • Palumbo Wealth Management's Immuneering position peaked at $416K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.